It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Iodide transport and storage in the thyroid follicles is crucial for thyroid hormone synthesis. Pendrin, the iodide exporter that transports iodide to thyroid follicles, is responsible for Pendred syndrome, a disorder characterized by congenital hypothyroidism and hearing loss. However, thyroid hormone levels are basically normal in patients with Pendred syndrome, indicating the presence of another unknown iodide transporter. Here, we show that SLC26A7 is a novel iodide transporter in the thyroid. We observe that SLC26A7 is specifically expressed in normal thyroid tissues and demonstrate its function in iodide transport. Using whole-exome sequencing, we also find a homozygous nonsense mutation in SLC26A7 (c.1498 C > T; p.Gln500Ter) in two siblings with congenital goitrous hypothyroidism. The mutated SLC26A7 protein shows an abnormal cytoplasmic localisation and lacks the iodide transport function. These results reveal that SLC26A7 functions as a novel iodide transporter in the thyroid and its dysfunction affects thyroid hormonogenesis in humans and causes congenital goitrous hypothyroidism.
Jun Ishii and Atsushi Suzuki et al. report the identification of SLC26A7 as a novel iodide transporter expressed in the thyroid. They identify a nonsense mutation in SLC26A7 in siblings with congenital hypothyroidism and goitre using whole-exome sequencing, implicating this transporter in disease.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details


1 Kyorin University School of Medicine, Department of Pathology, Tokyo, Japan (GRID:grid.411205.3) (ISNI:0000 0000 9340 2869); Dokkyo Medical University, Department of Pathology, Tochigi, Japan (GRID:grid.255137.7) (ISNI:0000 0001 0702 8004)
2 Nagoya City University Graduate School of Medical Sciences, Department of Pediatrics and Neonatology, Nagoya, Japan (GRID:grid.260433.0) (ISNI:0000 0001 0728 1069)
3 Kyorin University School of Medicine, Department of Pharmacology and Toxicology, Tokyo, Japan (GRID:grid.411205.3) (ISNI:0000 0000 9340 2869)
4 National Institute for Physiological Sciences, Division of Biophysics and Neurobiology, Department of Molecular and Cellular Physiology, Okazaki, Japan (GRID:grid.467811.d) (ISNI:0000 0001 2272 1771)
5 Dokkyo Medical University, Department of Pathology, Tochigi, Japan (GRID:grid.255137.7) (ISNI:0000 0001 0702 8004)
6 Kyorin University School of Medicine, Department of Pathology, Tokyo, Japan (GRID:grid.411205.3) (ISNI:0000 0000 9340 2869)
7 Nagoya City University Graduate School of Medical Sciences, Department of Pediatrics and Neonatology, Nagoya, Japan (GRID:grid.260433.0) (ISNI:0000 0001 0728 1069); International University of Health and Welfare, School of Medicine, Department of Pediatrics, Narita, Japan (GRID:grid.411731.1) (ISNI:0000 0004 0531 3030)